ASX:NXS Next Science (NXS) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free NXS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume86,564 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Next Science alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. About Next Science Stock (ASX:NXS)Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the issues in human health caused by biofilms in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for postoperative wound; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia.Read More Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. NXS Stock News HeadlinesApril 12, 2024 | msn.comNASA Prepares to Test Next-Gen Solar Sail TechnologyApril 8, 2024 | msn.comASX Health Stocks: Patrys and Next Science jump after presenting data on studiesApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? April 8, 2024 | reuters.comTotal solar eclipse 2024: When is it and what to expect?March 28, 2024 | tmcnet.comNASA Awards Promote Science, Technology, Engineering, Math NationwideMarch 26, 2024 | yahoo.comScience Museum: New gallery about future energy opensMarch 21, 2024 | msn.comNSU hosts regional high school science fairMarch 20, 2024 | msn.comBusinesses partner with Cambridge Science Centre to increase access to STEM educationApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? March 19, 2024 | msn.comSamsung builds lab to research next-gen AI chips; SK Hynix starts mass production of new chipMarch 18, 2024 | marketwatch.comScience Applications Shares Down After 4Q Adj. EPS MissMarch 18, 2024 | yahoo.comNow’s Your Chance To Play HoYoverse’s Next Game Ahead Of LaunchMarch 8, 2024 | msn.comNatural World And AI Take Top Honors at Middle School Science FairMarch 4, 2024 | finance.yahoo.comNext Science Full Year 2023 Earnings: US$0.069 loss per share (vs US$0.06 loss in FY 2022)March 1, 2024 | yahoo.comStudents in Monroe County celebrate Science DayMarch 1, 2024 | yahoo.comShure's MXW neXt 2 Now Certified for Microsoft TeamsFebruary 29, 2024 | finance.yahoo.comWill Next Science (ASX:NXS) Spend Its Cash Wisely?February 9, 2024 | yahoo.comThe onX Effect: Digital Mapping Apps Have Changed the Way We Hunt. Now What Will They Do With All Our Data?January 26, 2024 | yahoo.comFiber Innovators Explore Next-Gen Silk, Inditex Debuts Jacket Made From Textile WasteJanuary 10, 2024 | morningstar.comNext Science Ltd NXSJanuary 4, 2024 | yahoo.comThe 10 Science Moments You Need to Care About in 2024November 14, 2023 | msn.com'High school dropouts can still be successful'October 31, 2023 | businesswire.comNexthink Commits to reach a Net-Zero Standard by 2050October 13, 2023 | msn.comA scientist may have just proven that we all live inside a computer simulationOctober 11, 2023 | msn.comMoment of Science: EclipsesOctober 1, 2023 | msn.comDr Boreham’s Crucible: With a US focus, can Next Science’s new leaders stem the bleeding?September 24, 2023 | msn.comScience paints new picture of the past, when we mixed and mated with other kinds of humansSee More Headlines Receive NXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Next Science and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:NXS CUSIPN/A CIKN/A Webwww.nextscience.com Phone61 2 8607 5124FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,270,000.00 Net Margins-73.36% Pretax MarginN/A Return on Equity-156.02% Return on Assets-65.58% Debt Debt-to-Equity Ratio7.50 Current Ratio3.64 Quick Ratio4.80 Sales & Book Value Annual Sales$22.18 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow17.23 Book ValueA$0.04 per share Price / BookN/AMiscellaneous Outstanding Shares291,700,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.04 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Harry Thomas HallMD, CEO & DirectorDr. Matthew Franco MynttiFounder & CTOMarc ZimmermanChief Financial OfficerMr. Jon SwansonChief Operating OfficerMr. Robert BellSenior Vice President of North American SalesMs. Gillian Maria Nairn AGIAB.A., BA, L.L.B., L.L.M., LLB, LLM, MAICD, Company SecretaryMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All CompetitorsInsidersHarry Hall(IV)Sold 200,000 sharesTotal: $54,400.00 ($0.27/share)Judith MitchellSold 420,000 sharesTotal: $220,500.00 ($0.53/share) NXS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Next Science own? Based on aggregate information from My MarketBeat watchlists, some companies that other Next Science investors own include Abbott Laboratories (ABT), AbbVie (ABBV), Goldman Sachs Physical Gold ETF (AAAU), Argo Investments (ARG), Arcturus Therapeutics (ARCT), Appen (APX), Afterpay (APT), Advanced Micro Devices (AMD), Altium (ALU) and Alector (ALEC). This page (ASX:NXS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Next Science Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
